The efficacy and safety of panitumumab plus irrinotecan-based chemotherapy in the treatment of metastatic colorectal cancer A meta-analysis

Chen Qiang; Cheng Minjing; Wang Zhuo; Zhao Shipeng

首页> 外文期刊>Medicine. >The efficacy and safety of panitumumab plus irrinotecan-based chemotherapy in the treatment of metastatic colorectal cancer A meta-analysis

【24h】

The efficacy and safety of panitumumab plus irrinotecan-based chemotherapy in the treatment of metastatic colorectal cancer A meta-analysis

机译：帕尼单抗联合以伊立替康为基础的化学疗法治疗转移性结直肠癌的疗效和安全性荟萃分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Panitumumab, a fully human monoclonal antibody targeting epidermal growth factor receptor, is used in combination with chemotherapy for patients with metastatic colorectal cancer (mCRC). However, the effects of panitumumab in combination with irrinotecan-based chemotherapy remain uncertain. Therefore, we conducted this meta-analysis to assess the efficacy and safety of combination treatment of panitumumab plus chemotherapy in the treatment of mCRC.

机译：背景：Panitumumab是靶向表皮生长因子受体的完全人类单克隆抗体，与转移性结直肠癌（mCRC）患者联合使用。然而，帕尼单抗联合以伊立替康为基础的化学疗法的效果仍不确定。因此，我们进行了这项荟萃分析，以评估帕尼单抗联合化疗联合化疗治疗mCRC的疗效和安全性。

著录项

来源
《Medicine.》 |2016年第50期|共8页
作者
Chen Qiang; Cheng Minjing; Wang Zhuo; Zhao Shipeng;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词
chemotherapy; irinotecan; meta-analysis; metastatic colorectal cancer; panitumumab;

机译：化疗;伊立替康;meta分析;转移性结直肠癌;帕尼单抗;

相似文献

外文文献
中文文献
专利

1. The efficacy and safety of panitumumab plus irrinotecan-based chemotherapy in the treatment of metastatic colorectal cancer: A meta-analysis [J] . Chen Qiang, Cheng Minjing, Wang Zhuo, Medicine. . 2016,第50期

机译：帕尼单抗联合以伊立替康为基础的化学疗法治疗转移性结直肠癌的有效性和安全性：一项荟萃分析
2. The efficacy and safety of adding bevacizumab to cetuximab- or panitumumab-based therapy in the treatment of patients with metastatic colorectal cancer (mCRC): a meta-analysis from randomized control trials [J] . Yingqian Lv, Zixin Yang, Li Zhao, International Journal of Clinical and Experimental Medicine . 2015,第1期

机译：在基于西妥昔单抗或帕尼单抗的治疗中添加贝伐单抗治疗转移性结直肠癌（mCRC）的有效性和安全性：一项来自随机对照试验的荟萃分析
3. The efficacy and safety of panitumumab in the treatment of patients with metastatic colorectal cancer: a meta-analysis from five randomized controlled trials [J] . Ruo-feng Liang, Lei-lei Zheng Drug Design, Development and Therapy . 2015,第4期

机译：帕尼单抗治疗转移性结直肠癌的疗效和安全性：来自五个随机对照试验的荟萃分析
4. Correlation between development of hypertension and efficacy in metastatic colorectal cancer patients treated with bevacizumab [C] . Horinouchi Y., Sakurada T., Nakamura T., European Association for Clinical Pharmacology and Therapeutics . 2011

机译：北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
5. Investigating age varying effect of access to cancer care on immediate choice of chemotherapy among elderly women with metastatic breast cancer. [D] . Wan, Shaowei. 2010

机译：调查在转移性乳腺癌的老年妇女中，癌症治疗对立即选择化疗的年龄差异影响。
6. The efficacy and safety of panitumumab plus irrinotecan-based chemotherapy in the treatment of metastatic colorectal cancer [O] . Qiang Chen, Minjing Cheng, Zhuo Wang, -1

机译：帕尼单抗联合以伊立替康为基础的化学疗法治疗转移性结直肠癌的疗效和安全性
7. The efficacy and safety of panitumumab in the treatment of patients with metastatic colorectal cancer: a meta-analysis from five randomized controlled trials [O] . Lei-lei Zheng, Ruo-feng Liang 2015

机译：Panitumumab在转移结直肠癌患者治疗中的疗效和安全性：五种随机对照试验中的荟萃分析

The efficacy and safety of panitumumab plus irrinotecan-based chemotherapy in the treatment of metastatic colorectal cancer A meta-analysis

摘要

著录项

相似文献

相关主题

期刊订阅